Under a "statement of intent" signed last week, the two institutions plan to "initiate and develop a working relationship" and to explore areas of mutual interest in healthcare and discovery "with the common goal of creating value from the massive output of genomic information enabled by next-generation high-throughput DNA sequencing and analysis technologies."